Tianjin Chase Sun Pharmaceutical Co., Ltd. is a high-risk Pharmaceuticals company based in China with a Risk Rating Score of 38.7. Specializing in Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet-based therapy. The company focuses on ESG principles in its operations.